Table 1: Myopic FRD patients´ general and demographic data.

 

Study Group (35 eyes)

Control Group (22 eyes)

Variable

Mean

Standard deviation

Mean

Standard deviation

Age (years)

60.09

± 7.98

59.91

± 6.26

Axial length (mm)

29.50
(26.80 to 33.32)

± 1.59

29.62
(26.80 to 33.32)

± 1.65

Follow-up (months)

23.86

± 12.10

24.78

± 12.32

Mean time preoperative FRD evolution (months)

6.20

 

± 3.50

 

6.41

 

± 3.50

 

Mean time postoperative FRD resolution (weeks) – in patients without progression to MH/MHRD

4.94

± 2.08

 

3.77

± 1.48

 

Preoperative BCVA (logMAR)

0.87

± 0.15

0.89

± 0.15

Final BCVA (logMAR)

0.48

± 0.52

0.87

± 0.71

 

 

 

 

 

 

n

%

n

%

Female gender

27

77.14

18

81.81

Right eye

18

51.43

12

54.54

Phakic

12

34.29

13

59.09

Additional retinal surgery

7

20.00

8

36.36

Complications:

10*

28.57

11*

50.00

DCRA

2

5.71

2

9.09

MH

2

5.71

4

18.18

MHRD

1

2.85

5

22.73

RRD

3

8.57

0

0

Refractory foveoschisis

1

2.85

1

4.55

Non-resolved FRD

1

2.85

0

0

Residual non-foveal ERM

1

2.85

1

4.55

Localized RPE Foveoschisis

2

5.71

1

4.55

FRD: Foveoretinal Detachment; ERM: Epiretinal Membrane; MH: Macular Hole; BCVA: Best Corrected Visual Acuity; MHRD: Macular Hole with Retinal Detachment; RRD: Rhegmatogenous Retinal Detachment.
*Percentages for individual complications may add up to more than the total, as eyes may experience more than one type of complication.